Triple combination therapy for clinically nonmetastatic super‐high‐risk prostate cancer

INTRODUCTION: Patients with nonmetastatic but exceptionally high‐risk prostate cancer are liable to have biochemical failure and may even die. Triple combination therapy, which consists of surgery, radiotherapy, and androgen‐deprivation therapy, as first‐line treatment, may control the disease for a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshimura, Koji, Muraoka, Kei, Fukasawa, Michiko, Fukushima, Mika, Kumagai, Masatoshi, Yabusaki, Ryo, Ueda, Masakatsu, Shiraishi, Yusuke, Imamura, Masaaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249652/
https://www.ncbi.nlm.nih.gov/pubmed/35795109
http://dx.doi.org/10.1002/iju5.12457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249652/
https://www.ncbi.nlm.nih.gov/pubmed/35795109
http://dx.doi.org/10.1002/iju5.12457

Ejemplares similares